Skip to content

Effect of buccal acupuncture combined with Ondansetron on the prevention of PONV in laparoscopic cholecystectomy under ERAS philosophy

Effect of buccal acupuncture combined with Ondansetron on the prevention of PONV in laparoscopic cholecystectomy under ERAS philosophy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300069767
Enrollment
Unknown
Registered
2023-03-24
Start date
2023-01-28
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative nausea and vomiting(PONV)

Interventions

A:Ondansetron
B:buccal acupuncture
C:Buccal acupuncture combined with ondansetron

Sponsors

Dezhou Hospital (formerly Dezhou People's Hospital), Qilu Hospital of Shandong University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
30 Years to 64 Years

Inclusion criteria

Inclusion criteria: (1) ASA grade ?~?, age 30~64 years old, female; (2) 18.5kg/m2<BMI<28kg/m2; (3) Patients entering ERAS process and undergoing laparoscopic cholecystectomy under general anesthesia; (4) After fully understanding the purpose and significance of this experiment, participants should voluntarily participate in this experiment and sign the informed consent.

Exclusion criteria

Exclusion criteria: (1) Patients with nausea and vomiting due to current digestive diseases, history of vertigo, migraine disease, smoking, hypertension grade ? or above, severe arrhythmia, angina pectoris, heart failure, severe abnormal liver and kidney function, neuropsychiatric diseases; (2) A long history of opioid use; (3) Patients not managed according to ERAS; (4) Patients who received antiemetic, non-steroidal anti-inflammatory drugs, or opioids within 48 hours before surgery that might interfere with the intervention; (5) Patients with cognitive impairment, or can not tolerate acupuncture and moxibustion, poor compliance, poor expression; (6) Allergic to ondansetron; (7) Severe nausea and vomiting due to water and electrolyte disturbance, or severe surgical complications; (8) Pregnant women, cheek plastic surgery, botox injection history and other special patients.

Design outcomes

Primary

MeasureTime frame
postoperative nausea and vomiting;

Secondary

MeasureTime frame
postoperation pain;Vital signs during anesthesia ;Use of remedial antiemetic drugs ;The amount of narcotic drugs used;Adverse events;Postoperative recovery (time of first drinking water, time of liquid intake, time of first getting out of bed, time of first exhaust, time of postoperative discharge);intraoperative awareness;Postoperative analgesic drug use;

Countries

China

Contacts

Public ContactJianlei Qiu

Dezhou Hospital (formerly Dezhou People's Hospital), Qilu Hospital of Shandong University

46296669@qq.com15589166267

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026